Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.

Date publication

avril 2017

Journal

Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BARTHELEMY Philippe , Dr BOREL Christian , Dr BURGY Mickaël

Tous les auteurs :
Burgy M, Barthélémy P, Lefevre F, Dupret-Bories A, Truntzer P, Korenbaum C, Flesch H, Bronner G, Borel C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28423384

Résumé

The cetuximab plus platinum-based chemotherapy regimen is a standard of care in the treatment of recurrent or metastatic head and neck squamous-cell carcinoma (HNSCC). The feasibility in the elderly population is currently unknown.

Mots clés

Cetuximab, Chemotherapy, Elderly patients, Recurrent or metastatic head and neck squamous-cell carcinoma

Référence

Oncology. 2017 Apr;: